Next Article in Journal
Formation of Multicolor Nanogels Based on Cationic Polyfluorenes and Poly(methyl vinyl ether-alt-maleic monoethyl ester): Potential Use as pH-Responsive Fluorescent Drug Carriers
Previous Article in Journal
Cilia, Centrosomes and Skeletal Muscle
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Functional Polyglycidol-Based Block Copolymers for DNA Complexation

1
Institute of Polymers, Bulgarian Academy of Sciences, 1113 Sofia, Bulgaria
2
Department of Material Science and Technology, University “Prof. Assen Zlatarov”, 8010 Burgas, Bulgaria
3
Institute of Molecular Biology, Bulgarian Academy of Sciences, 1113 Sofia, Bulgaria
*
Authors to whom correspondence should be addressed.
Int. J. Mol. Sci. 2021, 22(17), 9606; https://doi.org/10.3390/ijms22179606
Submission received: 26 July 2021 / Revised: 30 August 2021 / Accepted: 1 September 2021 / Published: 4 September 2021
(This article belongs to the Section Macromolecules)

Abstract

:
Gene therapy is an attractive therapeutic method for the treatment of genetic disorders for which the efficient delivery of nucleic acids into a target cell is critical. The present study is aimed at evaluating the potential of copolymers based on linear polyglycidol to act as carriers of nucleic acids. Functional copolymers with linear polyglycidol as a non-ionic hydrophilic block and a second block bearing amine hydrochloride pendant groups were prepared using previously synthesized poly(allyl glycidyl ether)-b-polyglycidol block copolymers as precursors. The amine functionalities were introduced via highly efficient radical addition of 2-aminoethanethiol hydrochloride to the alkene side groups. The modified copolymers formed loose aggregates with strongly positive surface charge in aqueous media, stabilized by the presence of dodecyl residues at the end of the copolymer structures and the hydrogen-bonding interactions in polyglycidol segments. The copolymer aggregates were able to condense DNA into stable and compact nanosized polyplex particles through electrostatic interactions. The copolymers and the corresponding polyplexes showed low to moderate cytotoxicity on a panel of human cancer cell lines. The cell internalization evaluation demonstrated the capability of the polyplexes to successfully deliver DNA into the cancer cells.

Graphical Abstract

1. Introduction

The basic principle of gene therapy consists of exogenous delivery of foreign genetic material into target cells to promote a therapeutic effect in patients by adding, replacing, or editing a gene that is absent or abnormal or by knocking out the expression of a mutated gene [1,2,3]. It has the potential to shift the way numerous acquired and hereditary genetic diseases are managed and treated, in which the delivery of nucleic acids is crucial. Engineered viruses have been the first gene delivery agents. Although efficient, they appeared quite risky for the patient because of their inherent immunogenic nature, severe side effects, and high toxicity, which hampered their clinical applications [4,5,6]. The documented danger of the viral carriers has motivated the exploration of gene delivery alternatives based on lipids, polymers, and inorganic materials [7,8], which are safer, less pathogenic, and less immunogenic. Among them, polymer-based vectors have attracted intensive research interest [9,10,11,12,13]. In addition to the potential safety benefits, polymers offer great structural and chemical versatility for manipulating the physicochemical properties, access to large scale production, batch to batch reproducibility, large nucleic acid loading capacity, stability upon storage, low cost of treatment, all of them being advantageous for such a complex and complicated process such as gene therapy.
The polymeric vectors typically exploit the anionic nature of DNA to drive complexation via electrostatic interactions. Cationic polymers such as polyethyleneimine (PEI), poly(L-lysine) (PLL), poly(2-(dimethylamino)ethyl methacrylate) (PDMAEMA), and polyamidoamine, as well as natural polymers such as chitosan, dextran, and pullulan, are able to condense the bulky structure of DNA into nanosized complexes (polyplexes) [14,15]. The condensation also ensures neutralization of the negatively charged phosphate backbone of DNA and its protection from both extracellular and intracellular nuclease degradation. Ideally, DNA should remain active and capable of transfecting cells. However, the significant cytotoxicity of the cationic polymers, as well as the fast recognition by the reticuloendothelial system (RES) and rapid blood clearance of the polyplexes, are still an issue. The uptake by the RES can be suppressed and cytotoxicity reduced by incorporation of hydrophilic, flexible polymer moieties/segments. Besides, they can enhance the colloidal stability, favorably influence the physicochemical properties, and introduce functionalities that can be helpful in overcoming biological barriers to gene delivery. However, all those benefits of incorporation of additional moieties are frequently negated by the ubiquitous reduction in efficiency so that the delicate balance between apparently conflicting functions and properties should always be sought.
Building from the success of PEGylation of, firstly, proteins and later drugs and nanoparticles, it is not surprising that poly(ethylene glycol) (PEG) has been the most commonly employed for modification of cationic polymer-based polyplexes [16,17,18]. The role of PEG coatings is commonly associated with increasing solubility, imparting steric stabilization and stealth properties, preventing aggregation, decreasing cytotoxicity and immunogenicity, reducing opsonization and phagocytosis, and prolonging systemic circulation time. PEG coatings were also utilized for overcoming various biological barriers to efficient drug and gene delivery as described elsewhere [19,20,21,22].
Closely related to PEG and imparting essentially the same properties are polymers of oligo(ethylene glycol) methacrylates (OEGMAs). OEGMAs are easily polymerizable by controlled radical polymerizations allowing for a broad range of linear and non-linear random and block copolymers, including copolymers with polycationic moieties, exhibiting potential in gene delivery [23,24,25,26]. In contrast to PEG, the macromolecules of POEGMAs are considerably thicker and bulkier. They are composed of hydrophilic side chains of oligo(ethylene glycol) and a hydrophobic methacrylate main chain, which imparts amphiphilic properties: POEGMAs with side chains length shorter than nine oxyethylene units exhibit thermoresponsive behavior in aqueous solution [27,28,29].
A convenient source for obtaining linear PEI by acidic or basic hydrolysis is the poly(2-oxazoline)s (POx) [30,31,32,33,34,35]. The latter polymers can be produced by living cationic ring-opening polymerization of 2-oxazolines, which provides access to a variety of well-defined polymers [30,31]. POx are versatile with a range of end-group and side-chain functionalization. Their properties, in particular water solubility, can be easily tuned by varying the side chain of the 2-oxazoline monomer: POx with short side chains (methyl, ethyl, propyl, iso-propyl) are water-soluble and/or thermoresponsive polymers, whereas longer aliphatic or aromatic substituents result in hydrophobic polymers. POx exhibit excellent biocompatibility with various biological systems and represent an attractive platform for the development of biomaterials [31,32,36]. Those with short alkyl side chain substituents are considered promising alternatives to PEG. Of particular importance is the partial hydrolysis of POx by which PEI segments in desired quantities and distribution can be introduced [37]. The resulting POx-PEI copolymers combine PEI moieties capable of binding nucleic acids with hydrophilic and/or thermoresponsive, biocompatible, and biologically tolerant POx moieties [37].
Exploiting the concept of seeking a proper balance between safety and efficiency, we suggest another hydrophilic, non-ionic, and biologically tolerant polymer, which shows promise for the development of biomaterials and for other biomedical applications: linear polyglycidol (PG). PG is structurally similar to PEG: it possesses a polyether backbone (see Scheme 1 for the chemical structure of PG), in which, unlike PEG, pendant hydroxymethylene groups in each repeating monomer unit are introduced. The introduction of numerous hydroxyl groups enriches the possibilities for post-polymerization modification, but it is also manifested in the alteration of the properties of PG as compared to those of PEG. The hydroxyl groups were reported to promote the formation of a strongly hydrogen-bonded PG layer around hydrophobic domains of PG-based copolymers and non-phospholipid PG conjugates, which resulted in drastic changes in the aqueous solution properties and biological performance of these materials [38,39,40,41,42,43]. The present study aimed at evaluating the potential of copolymers based on linear polyglycidol to act as carriers of nucleic acids. From the library of PG-based copolymers studied earlier [38,41,42,43], we selected diblock copolymers of polyglycidol and poly(allyl glycidyl ether) (PAGE) bearing C12 hydrocarbon residue (hereinafter, C12-PAGE-PG). The PAGE moieties were modified by a thiol-ene click reaction to introduce a strong positive charge at each repeating unit. We set out to characterize the polyplex particles that are formed upon electrostatic interactions with DNA and evaluate the biocompatibility and ability to introduce DNA into cells.

2. Results and Discussion

2.1. Synthesis and Characterization of Amine-Functionalized Block Copolyethers

The copolymer precursors, abbreviated C12-PAGE-PG25 and C12-PAGE-PG60, were synthesized by sequential anionic ring-opening polymerization of allyl glycidyl ether (AGE) and ethoxyethyl glycidyl ether (protected glycidol) followed by removal of the protective ethoxyethyl groups as described elsewhere [42]. The hydrophobic hydrocarbon residue was introduced by the initiation of the polymerization with partially deprotonated dodecanol. The high degree of control over the polymerization of the two monomers, as well as the quantitative removal of the protective groups, allowed precise adjustment of the copolymer composition. The two copolymer precursors comprised a hydrophobic dodecyl residue attached to a block of PAGE with a fixed degree of polymerization and a block of PG of differing degrees of polymerization corresponding to PG contents of 25 and 60 mol % for C12-PAGE-PG25 and C12-PAGE-PG60, respectively (see Scheme 1 and Table 1 for the chemical structure, compositions and degrees of polymerization). The allyl functionality present in the PAGE block was exploited for orthogonal modification to introduce pendant primary amine hydrochloride groups. The synthetic procedure towards functionalization of the PAGE block is presented in Scheme 1.
The radical addition of 2-aminoethanethiol hydrochloride (AET·HCl) to the allylic double bonds was performed in DMF in the presence of AIBN. A 5-molar excess of the amine-functional thiol in hydrochloride form was used, and an increased temperature of 85 °C for an extended period of time was applied to ensure the complete modification. The quantitative conversion of the pendant alkene groups from the PAGE block was confirmed by 1H NMR spectroscopy (Figure 1). The signals at 5.84, 5.24, and 5.12 ppm characteristic for the three protons of the allylic double bond, as well as those at 3.93 ppm corresponding to the methylene protons next to the double bond completely disappeared from the 1H NMR spectrum in DMSO-d6 of the purified product (Figure 1b). Moreover, new resonances at 1.76, 2.58, 2.76, and 2.95 ppm attributed to the methylene protons of the pending amine-terminated side groups appeared. Interestingly, the resonance for the hydroxyl-group protons from the polyglycidol block of the precursor copolymer that is clearly visible at 4.55 ppm in its spectrum (Figure 1a) also completely disappeared in the amine-modified copolymer’s spectrum. These groups are not supposed to undergo any transformations during the modification step. Moreover, there are no additional resonances in the product’s NMR spectrum indicating such transformations. Actually, the formed amine-functionalized copolymers are extremely hygroscopic due to the presence of amine hydrochloride side groups on each repeating unit of the modified PAGE blocks leading to increased water content in the samples prepared for NMR analyses. As a result of the rapid exchange between OH protons from the polyglycidol block and H2O in the sample, they are not detectable in the NMR spectrum. Similar observations were reported in an 1H NMR study of poly(vinyl alcohol)/DMSO-d6/H2O system [44]. The block copolymer precursors’ and the amine-functionalized products’ characteristics are listed in Table 1.

2.2. Self-Association of the Amine-Functional Block Copolymers and DNA Condensation

By introducing amine functionality in the C12-PAGE-PG copolymers, reaction sites for electrostatic interactions with nucleic acids are created. These interactions drive the complexation between the modified copolymers (C12-PN-PG) and DNA, thereby condensing the bulky structure of the latter to appropriate size for cell internalization, neutralizing its negative charges, and protecting from nuclease degradation. Upon the modification, the initial moderately hydrophobic PAGE block was converted into a strongly hydrophilic one. However, despite the introduction of a large number of densely grafted, highly hydrophilic amine hydrochloride side groups, the amphiphilicity of the C12-PN-PG copolymers was not lost: in aqueous solution, the formation of large (175–185 nm) aggregates was detected (Figure 2, Table 1). These aggregates were comparable or larger than the particles that the parent C12-PAGE-PG copolymers formed [42] and of considerably broader particle size distributions (Table 1). Furthermore, well-defined, highly contrasted, well-separated, and high electron density objects were not observed by TEM. These findings implied the formation of multichain, loose, and seemingly, not well-defined aggregates. They are held together by two attractive interactions: hydrophobic interactions between the dodecyl residues, albeit weakened by the introduction of numerous hydrophilic protonated amino side groups, and hydrogen bonding via the hydroxyl groups from the PG moieties [39]. The practically identical values of the ζ potential of the aggregates of the two copolymers (Table 1) indicated that the polycation segments are mixed with the PG chains so that the effect of the longer polyglycidol chains of C12-PN-PG60 was lost. However, the strongly positive ζ potential of the C12-PN-PG aggregates (Table 1), which is considered advantageous as far as complexation with oppositely charged nucleic acids is concerned, is noteworthy.
The complexation was performed by slow addition of an aqueous DNA stock solution (100 µg·mL−1) to an equal volume of block copolymer dispersions with various concentrations to achieve the desired [N]/[P] ratios. The formation of polyplexes, as well as the variations in their size and ζ potential, were followed by dynamic and electrophoretic light scattering. Static light scattering was utilized to assess parameters such as scattered light intensity (I90) and radius of gyration (Rg). In the case of C12-PN-PG25, starting from [N]/[P] = 1:1, a significant reduction in both particle size and size distribution was observed as compared to the block copolymer aggregates alone (Table 1 and Table 2), implying the formation of better defined and more compact and dense particles. The further increase of [N]/[P] led to an additional reduction in particle size, reaching an average diameter of about 80 nm at the highest [N]/[P] ratio studied, [N]/[P] = 10:1 (Figure 2a, Table 2). Other indications for the formation of more compact and dense particles upon complexation are the changes in the scattered light intensity (I90) and the quantity Rg/Rh compared to those of the initial copolymer aggregates (Figure 3a and Figure 4a). Indeed, at approximately equal total concentrations, the scattered light intensity of the polyplexes was ca. one order of magnitude higher (Figure 3a), indicating an increase in the molar mass, which was accompanied by a reduction in the particle size as noted above. The simultaneous increase in I90 (hence, molar mass) and size reduction indicated an increase in the density of the material within the particle. Furthermore, upon complexation, the radius of gyration, Rg, was found to decrease more quickly and more strongly than the hydrodynamic radius, Rh (Table S1), which generated variations in the quantity Rg/Rh (Figure 4a). The latter gives useful information on the particle density and structure [45,46]. Here, Rg was obtained from the partial Berry plots, whereas Rh was calculated from the angular dependence of the relaxation rate as described in Supplementary Materials. Representative plots are shown in Figures S1 and S2, whereas the results are collected in Table S1. As seen from Figure 4a, Rg/Rh of the investigated systems dropped down from a value of about 1.2 for the initial copolymer aggregates to values in the 0.91–1.04 range for the complexes, typifying more compact structures [45,46].
The variations in the ζ potential showed an abrupt transition from highly negative to highly positive values within a very narrow [N]/[P] range with no changes upon further increase of [N]/[P] (Table 2). The strongly positive ζ potential at [N]/[P] ≥ 2.5, comparable with that of the initial copolymer aggregates (see Table 1 and Table 2), indicated the formation of polyplex particles, which apparently were not segregated into a water-insoluble core consisting of complexed oppositely charged segments of PN and DNA surrounded by PG chains building a shell. Most probably, polycation segments, not involved in the complexation with DNA, were mixed with PG chains in the outwards of the particles. Such an arrangement would satisfactorily explain the experimental results.
The behavior of the copolymer of higher PG content, C12-PN-PG60, in many aspects is similar to that of C12-PN-PG25, implying that the same events took place upon complex formation with DNA: sharp transition from strongly negative to strongly positive ζ potential values (Table 2); comparable ζ potential values of the polyplexes at higher [N]/[P] ratios with that of the initial C12-PN-PG60 aggregates (Table 1 and Table 2); a simultaneous increase in the scattered light intensity by order of magnitude (Figure 3b) and reduction in the size (Table 2) and quantity Rg/Rh (Figure 4b) into lower values. However, some of the effects, particularly the variations in the size of polyplex particles (Figure 2b and Table 2) and, to some extent, particle size distribution (Table 2) and reduction in Rg/Rh (Figure 4b), were less well pronounced. This could be attributed to the longer PG chain, which may compensate for the shrinkage of the particles upon complexation with DNA, thus making the differences less dramatic. The data obtained from dynamic, static, and electrophoretic light scattering measurements suggest that the electrostatic interactions between the oppositely charged groups of DNA and C12-PN-PG copolymers, leading to charge neutralization, are strong enough to convert the initial loose polymer aggregates into more hydrophobic, better defined, and more compact and dense polyplex particles.
The polyplexes’ morphology was visualized by TEM. The images show clusters of aggregated spherical nanoparticles with sizes that are somewhat smaller than those obtained from DLS measurements (Figure 5). The measured smaller average sizes are most likely due to shrinkage of particles as a result of dehydration upon sample preparation. The spherical shape of the polyplexes is clearly visible from the image of an individual particle (Figure 5, inset).

2.3. In Vitro Cytotoxicity Assessment of Block Copolymers and Polyplexes

The cytotoxic profile of C12-PN-PG25 and C12-PN-PG60 copolymers and the corresponding polyplexes at various [N]/[P] ratios was evaluated in order to estimate the potential harmful effects. This test is very important as the polymers utilized so far as non-viral vectors for gene therapy demonstrate noticeable cytotoxicity, which is one of the main drawbacks. The cytotoxicity of non-viral vectors depends on a number of physicochemical parameters such as particle size, morphology, and ζ potential that can also affect the gene delivery process [47]. The experiments were performed with three human cell lines, A549 (lung adenocarcinoma), MCF-7 (breast cancer), and HeLa (cervical cancer), that were exposed to different concentrations of pure copolymers and their corresponding polyplexes for 72 h. Cell viability was assessed by 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium salt (MTT). The calculated half-maximal inhibitory concentration (IC50) of C12-PN-PG25 and C12-PN-PG60 copolymers and corresponding polyplexes at various [N]/[P] is presented in Table 3. The HeLa cell line was further analyzed for more precise determination of cytotoxicity by another approach—a Trypan blue dye exclusion test. The pure copolymers were tested in a wider concentration range—from 12.5 to 200 µg·mL−1. The results are presented in Figure 6a. As seen, they are similar to those obtained by the MTT analysis.
The direct comparison of the IC50 values of the two copolymers showed slightly higher cytotoxicity for C12-PN-PG60 for two of the cell lines (Table 3). This was a somewhat surprising finding since the lower toxicity and higher biocompatibility of C12-PN-PG60 were anticipated due to its longer polyglycidol chains and higher polyglycidol content. The results can be rationalized in terms of similarities in the physicochemical parameters and derived structure of the aggregates of the two copolymers (Table 1): relatively large in size, loose particles, exhibiting strongly positive ζ potential and dimensions differing by less than 6%.
The IC50 values of the polyplexes of the two copolymers were found to generally increase with increasing [N]/[P]. This trend could also be correlated with the way polyplex particles change their dimensions, structure, and physicochemical parameters. As shown in the previous section, more compact and smaller in size structures are formed at higher [N]/[P] ratios. Apparently, the compact structure and smaller dimensions of the polyplex particles are beneficial as far as cytotoxicity and biocompatibility are concerned.
Considering the favorable characteristics of the polyplex particles at elevated [N]/[P] ratios, the polyplexes prepared at [N]/[P] ratios of 7.5:1 and 10:1 were further evaluated by a Trypan blue dye exclusion test on the HeLa human cell line. For these experiments, we chose a concentration range of DNA comparable with those regularly used in transfection experiments, namely, from 0.5 to 2.5 µg·mL−1 [48,49]. The results presented in Figure 6b,c showed low to moderate toxicity of the polyplexes. Only at a concentration of DNA of 5 µg·mL−1, which is outside the concentration range, in which DNA is typically used in transfection experiments [48,49], the cell viability was below IC50 (Figure 6b,c).

2.4. Cell Internalization of Polyplexes

To investigate the cellular uptake of the resulting polyplexes into the cells, SYBR Green-stained DNA (~2000 bp salmon sperm DNA) was used for complex formation. SYBR green is a commonly used cell-permeable fluorescent dye that intercalates non-specifically into double-stranded DNA. Upon interaction with double-stranded DNA molecules, the brightness of this fluorescent dye strongly (>1000-fold) increases. Prior to incubation, the salmon DNA was ethanol precipitated and re-dissolved in order to avoid SYBR Green staining of the cellular DNA. The results of microscopic observations are presented in Figure 7. It is evident that both copolymers were able to introduce DNA into cells. The effect was anticipated and attributed to the strong positive surface charge of the polyplex particles and their relatively small size and compact structure (Table 2, Figure 4, Section 2.2).
An increased cell penetration was observed 48 h after inoculation with complexes of both copolymers, indicating that (i) they were stable for at least 48 h in physiological conditions and (ii) longer time for internalization was needed. In the case of C12-PN-PG25 polyplexes, there was no visible difference in the level of penetration for both [N]/[P] ratios (Figure 7a, bottom line). In contrast, the level of penetration of the C12-PN-PG60 polyplexes at the [N]/[P] ratio of 7.5:1 was much more prominent (Figure 7b, bottom left image) than that at 10:1, implying that polyglycidol above certain critical length and/or content may have an effect of hindering of cellular uptake.

3. Materials and Methods

3.1. Materials and Reagents

All chemicals were purchased from Sigma-Aldrich. N,N-Dimehylformamide (DMF, ≥99.5%) was distilled from calcium hydride prior to use. α,α′-Azoisobutyronitrile (AIBN, 98%) was recrystallized from methanol. The 2-Aminoethanethiol hydrochloride (AET·HCl, ≥98%) was dried in a vacuum prior to use. A stock solution of 100 µg·mL−1 salmon sperm DNA (2000 bp, Mw ≈ 1.3 × 106 Da) was prepared in ultrapure water (>18 MΩ·cm) and used for complex formation. Well-defined amphiphilic block copolymers with pendant alkene and hydroxyl functional groups, as well as a dodecyl residue at the end of the chain (C12-PAGE-PG25 and C12-PAGE-PG60), were prepared by sequential anionic ring-opening polymerization of allylglycidyl ether (AGE) and ethoxyethyl glycidyl ether (protected glycidol) and subsequent cleavage of the protective groups as previously described [42]. The composition, molecular weights, and codes of the copolymer precursors are presented in Table 1.

3.2. Synthesis of Amine and Hydroxyl-Functional Copolyethers (C12-PN-PG)

Typically, the amphiphilic block copolymer C12-PAGE-PG25 with composition C12H25-(AGE)44-(G)16 (0.3 g, 2 mmol alkene groups), AIBN (0.125 g, 0.76 mmol), and AET·HCl (1.14 g, 10 mmol) were dissolved in 0.5 mL of freshly distilled DMF. The reaction mixture was degassed by bubbling argon for 30 min, and the reaction vessel was immersed into a preheated to 85 °C oil bath. The reaction proceeded at that temperature for 96 h. The mixture was diluted with distilled water, and the product was purified through ultrafiltration (membrane molecular weight cut-off: 1000 Da). The modified copolymer was recovered through lyophilization. Yield: 0.42 g, (79%). 1H NMR (600 MHz, DMSO-d6, δ, ppm): 0.86 (CH3), 1.24 (CH3-(CH2)10-), 1.76 (-O-CH2-CH2-CH2-), 2.58 (-CH2-S-CH2-), 2.76 (-CH2-S-CH2-CH2-), 2.95 (-S-CH2-CH2-NH3+), 3.25–3.75 (CH3-(CH2)10-CH2-O) + -O-CH2-CH-O- + -O-CH2-CH-O- + -CH(CH2-O-CH2-) + -CH(CH2-O-CH2-) + -O-CH2-CH(-CH2-OH)-O- + CH2-CH-(CH2-OH)-O- + CH2-CH(-CH2-OH)-O-).

3.3. Characterization

The 1H NMR spectra were recorded in DMSO-d6 on a Bruker Avance II+ 600 MHz instrument. The size distribution of the block copolymer aggregates was determined by dynamic light scattering (DLS) using a NanoBrook Plus PALS instrument (Brookhaven Instruments), equipped with a 35 mW solid-state laser operating at λ = 660 nm at a scattering angle of 90°. The particles’ hydrodynamic diameters (dh) were determined according to the Stokes–Einstein equation:
dh = kT/(3πηD)
where k is the Boltzmann’s constant, T is the absolute temperature, η is the solvent viscosity, D is the diffusion coefficient.
The ζ potentials were calculated from the obtained electrophoretic mobility by the Smoluchowski equation:
ζ = 4πηµ/ε
where η is the solvent viscosity, µ is the electrophoretic mobility, and ε is the dielectric constant of the solvent. The size and ζ potential measurements were carried out in an automated mode in triplicate and recorded as averages of 3 and 20 runs, respectively. The copolymers’ and polyplexes’ dispersions were passed through Millipore® 0.45 μm pore-sized Nylon syringe filters prior to measurements. Transmission electron microscopy (TEM) images were obtained using HRTEM JEOL JEM-4-2100 (200 kV) instrument equipped with CCD camera GATAN Orius 832 SC1000 and GATAN Microscopy Suite Software. The samples were prepared by depositing a drop of the polyplex solution onto a carbon grid and subsequent evaporation of the solvent. The images analysis was performed with ImageJ software.

3.4. DNA Condensation

Block copolymer aggregates were prepared by applying the direct dissolution method. A predetermined copolymer amount was dispersed in 1 mL of ultrapure water (18.2 MΩ·cm). An equal volume of DNA solution (100 µg·mL−1) was added dropwise under vigorous stirring (900 rpm, 2 min) at room temperature. The molar ratio between the positively charged groups of the block copolymers and the phosphate groups of the DNA ([N]/[P]) was varied from 1:1 to 10:1. The electrostatically formed complexes were gently stirred (150 rpm) at room temperature for 30 min and subjected to characterization.

3.5. Cell Lines and Culture Conditions

The cytotoxicity of amine-functionalized copolymers (C12-PN-PG25 and C12-PN-PG60) and the corresponding polyplexes at various [N]/[P] ratios were tested against three human cell lines. MCF-7 (breast cancer cell line) cells were grown in Eagle’s Minimum Essential Medium (Thermo Fisher Scientific, Waltham, MA, USA) with 0.01 mg·mL−1 human recombinant insulin (Sigma-Aldrich, Milwaukee, WI, USA), 10% fetal bovine serum (Thermo Fisher Scientific, Waltham, MA, USA), and penicillin-streptomycin (Thermo Fisher Scientific, Waltham, MA, USA). A549 (lung adenocarcinoma cell line) cells were plated in F-12K Medium (Thermo Fisher Scientific, Waltham, MA, USA) supplemented with 10% (v/v) fetal calf serum (FCS, Thermo Fisher Scientific, Waltham, MA, USA) and 1% penicillin/streptomycin solution (Thermo Fisher Scientific, Waltham, MA, USA). HeLa (cervical cancer) cells were plated in Dulbecco’s modified Eagle’s medium (DMEM, Gibco BRL, Waltham, MA, USA) supplemented with 10% (v/v) fetal calf serum (FCS, Life Technologies, Inc.) and 1% penicillin/streptomycin solution (Life Technologies, Inc., Waltham, MA, USA). All cell lines used in this study were purchased from ATCC (LGC STANDARDS, Teddington, UK). The cells were maintained in a 5% CO2 incubator at 37 °C. Only cells growing in the exponential phase were used for all experiments.

3.6. Cytotoxicity Assessment (Trypan Blue Exclusion Test)

The dye exclusion test to determine the percentage of viable cells was performed as described elsewhere [50]. In this assay, a cell suspension was mixed with Trypan blue dye and then examined to determine whether cells take up (death cells) or exclude the dye (live cells) by using automated cell counter Corning®. The percentage of viable cells was calculated according to the formula:
viable cells (%) = (total number of viable cells per mL of aliquot)/(total number of cells per mL of aliquot) × 100

3.7. Cytotoxicity Assessment (MTT-Dye Reduction Assay)

The cell viability was assessed using the standard MTT-dye reduction assay, as described previously [51], with some modifications [23]. The method is based on the biotransformation of the yellow tetrazolium salt MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide) to a violet formazan via the mitochondrial succinate dehydrogenase in the viable cells. Briefly, the exponentially growing cells were seeded in 96-well flat-bottomed micro-plates (Corning Costar Flat Bottom Cell Culture Plate) at a density of 1 × 104 cells per mL, 100 µL per well. After 24 h of incubation at 37 °C, the cells from each cell line were treated with the C12-PN-PG25 and C12-PN-PG60 copolymers and the corresponding polyplexes at various [N]/[P] ratios. After a 72 h incubation at conditions of 5% CO2 at 37 °C, the medium was changed to a phenol red-free medium, and MTT (Invitrogen) was added in a final concentration of 0.5 mg·mL−1. The cells were incubated for 2 h at conditions of 5% CO2 and 37 °C. Finally, 100 µL of DMSO per well were added to dissolve the formed formazan crystals. The measurement of the absorbance of the samples was performed on a Varioskan LUX Multimode Microplate Reader (Thermo Fisher Scientific) at 580 nm. GraphPad Prism software v.8 was used for data analysis.

3.8. Intracellular Localization

Salmon sperm DNA fragments (2000 bp) were pre-stained with SYBR green dye (Thermo Fisher Scientific) and then purified from the free dye by column filtration prior to use. Polyplexes were prepared at different [N]/[P] ratios varying from 1:1 to 10:1. The cells used in these experiments were plated at a density of 1 × 105 in 24-well dishes and cultivated for 24 h prior to the incubation with corresponding pre-stained polyplexes for 2 or 24 h. Images were obtained with a Zeiss Axiovert 200 M microscope using an Objective LD Plan-Neofluar 63x/0.75 Corr (D = 0–1.5 mm), equipped with a CCD camera AxioCam MRm driven by Axiovision v4.9 software (Carl Zeiss Microscopy LLC, White Plains, NY, USA), as described previously [23]. Three independent experiments were performed.

4. Conclusions

Radical addition of 2-aminoethanethiol hydrochloride to the allylic double bonds of two related in composition block copolymers of poly(allyl glycidyl ether) and polyglycidol was employed to orthogonally introduce pendant primary amine groups. The modification reaction proceeded with high efficiency to yield 100% functionalized copolymers. The introduction of the amine groups, turning the moderately hydrophobic PAGE blocks into strongly hydrophilic ones, did not prevent the aggregation of the copolymers: in aqueous solution, they formed relatively large, multichain, strongly positively charged and loose aggregates, held together by hydrophobic interactions between the dodecyl residues and hydrogen bonding from the polyglycidol moieties. These aggregates had the capacity to efficiently condense DNA via electrostatic interactions, thereby forming compact and dense polyplex particles. Although strongly positively charged at [N]/[P] ratios of above 2, the latter exhibited low to moderate toxicity, which was attributed to the biocompatibility of polyglycidol. The strongly positive ζ potential of the polyplex particles favored the interactions with the negatively charged cell membranes, which resulted in enhanced cell penetration. The polyplexes remained stable at physiological conditions for an extended period of 48 h, which can be related to additional stabilization of the polyplex structures via hydrogen bonding between the hydroxyl groups of the polyglycidol moieties. The polyglycidol content had no or only a little effect on the physicochemical characteristics of the initial aggregates, polyplex particles, and their biological performance, implying that polyglycidol content in the 25–60 mol % range is optimal. Overall, the results demonstrated the potential of appropriately modified polyglycidol-based copolymers as non-viral vectors for gene delivery.

Supplementary Materials

The following are available online at https://www.mdpi.com/article/10.3390/ijms22179606/s1, Figure S1: Relaxation rate (Γ) as a function of sin2(θ/2) for aqueous dispersions of polyplex particles prepared from (a) C12-PN-PG25 and DNA at [N]/[P] = 5.0:1 and (b) C12-PN-PG60 and DNA at [N]/[P] = 7.5:1. Figure S2: Partial Berry plots for determination of Rg of polyplex particles prepared from (a) C12-PN-PG25 and DNA at [N]/[P] = 10.0:1 and (b) C12-PN-PG60 and DNA at [N]/[P] = 5.0:1. Table S1: Static and dynamic light scattering parameters of the initial block copolymer aggregates and polyplexes with DNA at various [N]/[P] ratios in aqueous media.

Author Contributions

Conceptualization, I.D., S.T., I.U. and S.R.; data curation, M.P. and Z.V.; funding acquisition, I.U. and S.R.; investigation, R.K., M.V. and M.P.; methodology, R.K., M.V., S.T., I.U. and M.P.; project administration, I.U. and S.R.; validation, R.K., M.V. and Z.V.; visualization, R.K. and Z.V.; writing—original draft, I.D., I.U. and S.R.; writing—review and editing, I.D., I.U. and S.R. All authors have read and agreed to the published version of the manuscript.

Funding

The research in the synthesis/characterization/self-association/DNA condensation sections was supported by Operational Program “Science and Education for Smart Growth” 2014–2020, co-financed by European Union through the European Structural and Investment Funds, Grant BG05M2OP001-1.002-0012 “Sustainable utilization of bio-resources and waste of medicinal and aromatic plants for innovative bioactive products”. The research in the biological sections was supported by the Ministry of Education and Science of the Republic of Bulgaria supported by the National Program “Innovative Low-Toxic and Biologically Active Means for Precision Medicine”—BioActiveMed, grant number Д01-217/30.11.2018.

Institutional Review Board Statement

Not applicable.

Informed Consent Statement

Not applicable.

Conflicts of Interest

The authors declare no conflict of interest. The funders had no role in the design of the study; in the collection, analyses, or interpretation of data; in the writing of the manuscript, or in the decision to publish the results.

References

  1. Miller, A.D. Human gene therapy comes of age. Nature 1992, 357, 455–460. [Google Scholar] [CrossRef]
  2. Burton, E.A.; Glorioso, J.C.; Fink, D.J. Gene therapy progress and prospects: Parkinson’s disease. Gene Ther. 2003, 10, 1721–1727. [Google Scholar] [CrossRef] [PubMed]
  3. Cross, D.; Burmester, J.K. Gene Therapy for cancer treatment: Past, present and future. Clin. Med. Res. 2006, 4, 218–227. [Google Scholar] [CrossRef] [Green Version]
  4. Jooss, K.; Yang, Y.; Fisher, K.J.; Wilson, J.M. Transduction of dendritic cells by DNA viral vectors directs the immune response to transgene products in muscle fibers. J. Virol. 1998, 72, 4212–4223. [Google Scholar] [CrossRef] [Green Version]
  5. Marshall, E. Gene therapy death prompts review of adenovirus vector. Science 1999, 286, 2244–2245. [Google Scholar] [CrossRef]
  6. Check, E. A tragic setback. Nat. Cell Biol. 2002, 420, 116–118. [Google Scholar] [CrossRef]
  7. Sharma, D.; Arora, S.; Singh, J.; Layek, B. A review of the tortuous path of nonviral gene delivery and recent progress. Int. J. Biol. Macromol. 2021, 183, 2055–2073. [Google Scholar] [CrossRef] [PubMed]
  8. Mitchell, M.J.; Billingsley, M.M.; Haley, R.M.; Wechsler, M.E.; Peppas, N.A.; Langer, R. Engineering precision nanoparticles for drug delivery. Nat. Rev. Drug Discov. 2021, 20, 101–124. [Google Scholar] [CrossRef]
  9. Jones, C.H.; Chen, C.-K.; Ravikrishnan, A.; Rane, S.; Pfeifer, B.A. Overcoming nonviral gene delivery barriers: Perspective and future. Mol. Pharm. 2013, 10, 4082–4098. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  10. Trentin, D.; Hubbell, J.; Hall, H. Non-viral gene delivery for local and controlled DNA release. J. Control. Release 2005, 102, 263–275. [Google Scholar] [CrossRef] [PubMed]
  11. Wong, S.Y.; Pelet, J.M.; Putnam, D. Polymer systems for gene delivery—Past, present, and future. Prog. Polym. Sci. 2007, 32, 799–837. [Google Scholar] [CrossRef]
  12. O’Rorke, S.; Keeney, M.; Pandit, A. Non-viral polyplexes: Scaffold mediated delivery for gene therapy. Prog. Polym. Sci. 2010, 35, 441–458. [Google Scholar] [CrossRef]
  13. Pichon, C.; Billiet, L.; Midoux, P. Chemical vectors for gene delivery: Uptake and intracellular trafficking. Curr. Opin. Biotechnol. 2010, 21, 640–645. [Google Scholar] [CrossRef] [PubMed]
  14. Van den Berg, A.I.S.; Yun, C.-O.; Schiffelers, R.M.; Hennink, W.E. Polymeric delivery systems for nucleic acid therapeutics: Approaching the clinic. J. Control. Release 2021, 331, 121–141. [Google Scholar] [CrossRef]
  15. Rangelov, S.; Pispas, A. Polymer and Polymer-Hybrid Nanoparticles: From Synthesis to Biomedical Applications; CRC Press Taylor and Francis Group: Boca Raton, FL, USA, 2014. [Google Scholar]
  16. Yang, C.; Gao, S.; Dagnæs-Hansen, F.; Jakobsen, M.; Kjems, J. Impact of PEG chain length on the physical properties and bioactivity of PEGylated Chitosan/SiRNA nanoparticles In Vitro and In Vivo. ACS Appl. Mater. Interfaces 2017, 9, 12203–12216. [Google Scholar] [CrossRef]
  17. Venault, A.; Huang, Y.-C.; Lo, J.W.; Chou, C.-J.; Chinnathambi, A.; Higuchi, A.; Chen, W.-S.; Chen, W.-Y.; Chang, Y. Tunable PEGylation of branch-type PEI/DNA polyplexes with a compromise of low cytotoxicity and high transgene expression: In Vitro and In Vivo gene delivery. J. Mater. Chem. B 2017, 5, 4732–4744. [Google Scholar] [CrossRef] [PubMed]
  18. Santo, D.; Mendonça, P.V.; Lima, M.S.; Cordeiro, R.A.; Cabanas, L.; Serra, A.; Coelho, J.F.; Faneca, H. Poly(ethylene glycol)-block-poly(2-aminoethyl methacrylate hydrochloride)-Based Polyplexes as Serum-Tolerant Nanosystems for Enhanced Gene Delivery. Mol. Pharm. 2019, 16, 2129–2141. [Google Scholar] [CrossRef] [PubMed]
  19. Suk, J.S.; Xu, Q.; Kim, N.; Hanes, J.; Ensign, L.M. PEGylation as a strategy for improving nanoparticle-based drug and gene delivery. Adv. Drug Deliv. Rev. 2016, 99, 28–51. [Google Scholar] [CrossRef] [Green Version]
  20. Wang, Y.; Ye, M.; Xie, R.; Gong, S. Enhancing the In Vitro and In Vivo stabilities of polymeric nucleic acid delivery nanosystems. Bioconjug. Chem. 2019, 30, 325–337. [Google Scholar] [CrossRef] [PubMed]
  21. Zhong, Z.; Feijen, J.; Lok, M.C.; Hennink, W.E.; Christensen, L.V.; Yockman, J.W.; Kim, A.Y.-H.; Kim, S.W. Low Molecular Weight Linear Polyethylenimine-b-poly(ethylene glycol)-b-polyethylenimine Triblock Copolymers: Synthesis, Characterization, and In Vitro Gene Transfer Properties. Biomacromolecules 2005, 6, 3440–3448. [Google Scholar] [CrossRef]
  22. Kim, J.; Kang, Y.; Tzeng, S.Y.; Green, J.J. Synthesis and application of poly(ethylene glycol)-co-poly(β-amino ester) copolymers for small cell lung cancer gene therapy. Acta Biomater. 2016, 41, 293–301. [Google Scholar] [CrossRef]
  23. Haladjova, E.; Chrysostomou, V.; Petrova, M.; Ugrinova, I.; Pispas, S.; Rangelov, S. Physicochemical Properties and Biological Performance of Polymethacrylate Based Gene Delivery Vector Systems: Influence of Amino Functionalities. Macromol. Biosci. 2021, 21, e2000352. [Google Scholar] [CrossRef]
  24. Chroni, A.; Forys, A.; Trzebicka, B.; Alemayehu, A.; Tyrpekl, V.; Pispas, S. Poly[oligo(ethylene glycol) methacrylate]-b-poly[(vinyl benzyl trimethylammonium chloride)] Based Multifunctional Hybrid Nanostructures Encapsulating Magnetic Nanoparticles and DNA. Polymers 2020, 12, 1283. [Google Scholar] [CrossRef] [PubMed]
  25. Mendrek, B.; Fus-Kujawa, A.; Teper, P.; Botor, M.; Kubacki, J.; Sieroń, A.L.; Kowalczuk, A. Star polymer-based nanolayers with immobilized complexes of polycationic stars and DNA for deposition gene delivery and recovery of intact transfected cells. Int. J. Pharm. 2020, 589, 119823. [Google Scholar] [CrossRef]
  26. Vuoriluoto, M.; Orelma, H.; Johansson, L.-S.; Zhu, B.; Poutanen, M.; Walther, A.; Laine, J.; Rojas, O.J. Effect of Molecular Architecture of PDMAEMA–POEGMA Random and Block Copolymers on Their Adsorption on Regenerated and Anionic Nanocelluloses and Evidence of Interfacial Water Expulsion. J. Phys. Chem. B 2015, 119, 15275–15286. [Google Scholar] [CrossRef]
  27. Han, S.; Hagiwara, M.; Ishizone, T. Synthesis of Thermally Sensitive Water-Soluble Polymethacrylates by Living Anionic Polymerizations of Oligo(ethylene glycol) Methyl Ether Methacrylates. Macromolecules 2003, 36, 8312–8319. [Google Scholar] [CrossRef]
  28. Trzebicka, B.; Szweda, D.; Rangelov, S.; Kowalczuk, A.; Mendrek, B.; Utrata-Wesołek, A.; Dworak, A. (Co)polymers of oligo(ethylene glycol) methacrylates—temperature-induced aggregation in aqueous solution. J. Polym. Sci. Part A Polym. Chem. 2012, 51, 614–623. [Google Scholar] [CrossRef]
  29. Liu, M.; Leroux, J.-C.; Gauthier, M.A. Conformation–function relationships for the comb-shaped polymer pOEGMA. Prog. Polym. Sci. 2015, 48, 111–121. [Google Scholar] [CrossRef]
  30. Adams, N.; Schubert, U.S. Poly(2-oxazolines) in biological and biomedical application contexts. Adv. Drug Deliv. Rev. 2007, 59, 1504–1520. [Google Scholar] [CrossRef]
  31. Hoogenboom, R. Poly(2-oxazoline)s: A Polymer Class with Numerous Potential Applications. Angew. Chem. Int. Ed. 2009, 48, 7978–7994. [Google Scholar] [CrossRef] [PubMed]
  32. Schlaad, H.; Diehl, C.; Gress, A.; Meyer, M.; Demirel, A.L.; Nur, Y.; Bertin, A. Poly(2-oxazoline)s as Smart Bioinspired Polymers. Macromol. Rapid Commun. 2010, 31, 511–525. [Google Scholar] [CrossRef]
  33. Luxenhofer, R.; Han, Y.; Schulz, A.; Tong, J.; He, Z.; Kabanov, A.; Jordan, R. Poly(2-oxazoline)s as Polymer Therapeutics. Macromol. Rapid Commun. 2012, 33, 1613–1631. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  34. Brissault, B.; Kichler, A.; Guis, C.; Leborgne, C.; Danos, O.; Cheradame, H. Synthesis of Linear Polyethylenimine Derivatives for DNA Transfection. Bioconjug. Chem. 2003, 14, 581–587. [Google Scholar] [CrossRef]
  35. Lambermont-Thijs, H.M.L.; van der Woerdt, F.S.; Baumgaertel, A.; Bonami, L.; Du Prez, F.E.; Schubert, U.S.; Hoogenboom, R. Linear Poly(ethylene imine)s by Acidic Hydrolysis of Poly(2-oxazoline)s: Kinetic Screening, Thermal Properties, and Temperature-Induced Solubility Transitions. Macromolecules 2010, 43, 927–933. [Google Scholar] [CrossRef]
  36. Bludau, H.; Czapar, A.E.; Pitek, A.S.; Shukla, S.; Jordan, R.; Steinmetz, N.F. POxylation as an alternative stealth coating for biomedical applications. Eur. Polym. J. 2017, 88, 679–688. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  37. Haladjova, E.; Rangelov, S.; Tsvetanov, C. Thermoresponsive Polyoxazolines as Vectors for Transfection of Nucleic Acids. Polymers 2020, 12, 2609. [Google Scholar] [CrossRef] [PubMed]
  38. Halacheva, S.; Rangelov, S.; Tsvetanov, C. Poly(glycidol)-Based Analogues to Pluronic Block Copolymers. Synthesis and Aqueous Solution Properties. Macromolecules 2006, 39, 6845–6852. [Google Scholar] [CrossRef]
  39. Halacheva, S.; Rangelov, S.; Garamus, V.M. Structure and Interactions in Large Compound Particles Formed by Polyglycidol-Based Analogues to Pluronic Copolymers in Aqueous Solution. Macromolecules 2007, 40, 8015–8021. [Google Scholar] [CrossRef]
  40. Bakardzhiev, P.; Rangelov, S.; Trzebicka, B.; Momekova, D.; Lalev, G.; Garamus, V.M. Nanostructures by self-assembly of polyglycidol-derivatized lipids. RSC Adv. 2014, 4, 37208–37219. [Google Scholar] [CrossRef] [Green Version]
  41. Stoyanova, B.; Novakov, C.; Tsvetanov, C.B.; Rangelov, S. Synthesis and Aqueous Solution Properties of Block Copolyethers with Latent Chemical Functionality. Macromol. Chem. Phys. 2016, 217, 2380–2390. [Google Scholar] [CrossRef]
  42. Valchanova, M.; Yordanov, Y.; Tzankova, V.; Yoncheva, K.; Turmanova, S.; Rangelov, S. Functional amphiphilic block copolyethers as carriers of caffeic acid phenethyl ester. Polym. Int. 2019, 68, 1881–1890. [Google Scholar] [CrossRef]
  43. Yordanov, Y.; Aluani, D.; Tzankova, V.; Rangelov, S.; Odzhakov, F.; Apostolov, A.; Yoncheva, K. Safety assessment of a newly synthesized copolymer for micellar delivery of hydrophobic caffeic acid phenethyl ester. Pharm. Dev. Technol. 2020, 25, 1271–1280. [Google Scholar] [CrossRef]
  44. Hu, S.; Horii, F.; Odani, H. 1H NMR study of the solvation and gelation in a poly (vinyl alcohol)/DMSO-d6/H2O system. Bull. Inst. Chem. Res. Kyoto Univ. 1990, 67, 239–248. Available online: http://hdl.handle.net/2433/77317 (accessed on 12 March 2021).
  45. Burchard, W. Static and dynamic light scattering from branched polymers and biopolymers. Light Scatt. Polym. 2007, 48, 1–124. [Google Scholar] [CrossRef]
  46. Thurn, A.; Burchard, W.; Niki, R. Structure of casein micelles I. Small angle neutron scattering and light scattering from β- and χ-casein. Colloid Polym. Sci. 1987, 265, 653–666. [Google Scholar] [CrossRef]
  47. Agirre, M.; Zarate, J.; Puras, G.; Ojeda, E.; Pedraz, J.L. Improving transfection efficiency of ultrapure oligochitosan/DNA polyplexes 614 by medium acidification. Drug Deliv. 2015, 22, 100–110. [Google Scholar] [CrossRef] [Green Version]
  48. Kwon, M.; Firestein, B.L. DNA Transfection: Calcium Phosphate Method. Adv. Struct. Saf. Stud. 2013, 1018, 107–110. [Google Scholar] [CrossRef]
  49. Kumar, P.; Nagarajan, A.; Uchil, P.D. DNA Transfection Mediated by Cationic Lipid Reagents. Cold Spring Harb. Protoc. 2019, 2019. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  50. Strober, W. Trypan Blue Exclusion Test of Cell Viability. Curr. Protoc. Immunol. 2015, 111, A3.B.1–A3.B.3. [Google Scholar] [CrossRef]
  51. Mosmann, T. Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays. J. Immunol. Methods 1983, 65, 55–63. [Google Scholar] [CrossRef]
Scheme 1. Synthetic route to functional block copolymers with pendant primary amine hydrochloride groups.
Scheme 1. Synthetic route to functional block copolymers with pendant primary amine hydrochloride groups.
Ijms 22 09606 sch001
Figure 1. 1H NMR (600 MHz) spectra in DMSO-d6 of (a) amphiphilic block copolymer with alkene pendant groups (C12-PAGE-PG25) and (b) amine-functionalized block copolymer C12-PN-PG25.
Figure 1. 1H NMR (600 MHz) spectra in DMSO-d6 of (a) amphiphilic block copolymer with alkene pendant groups (C12-PAGE-PG25) and (b) amine-functionalized block copolymer C12-PN-PG25.
Ijms 22 09606 g001
Figure 2. Size-distribution curves from DLS measurements of aqueous dispersions of the block copolymer C12-PN-PG25 (a) and C12-PN-PG60 (b) and their polyplexes with DNA at [N]/[P] ratios of 7.5:1 and 10:1.
Figure 2. Size-distribution curves from DLS measurements of aqueous dispersions of the block copolymer C12-PN-PG25 (a) and C12-PN-PG60 (b) and their polyplexes with DNA at [N]/[P] ratios of 7.5:1 and 10:1.
Ijms 22 09606 g002
Figure 3. Variations in the scattered light intensity measured at an angle of 90° (I90) from dispersions of polyplexes of C12-PN-PG25 (a) and C12-PN-PG60 (b) with the [N]/[P] ratio. The lines through the data point are drawn to guide the eye. Data points are at [N]/[P] = 0 refer to the aggregates of the pure copolymers. Standard deviations ±2%.
Figure 3. Variations in the scattered light intensity measured at an angle of 90° (I90) from dispersions of polyplexes of C12-PN-PG25 (a) and C12-PN-PG60 (b) with the [N]/[P] ratio. The lines through the data point are drawn to guide the eye. Data points are at [N]/[P] = 0 refer to the aggregates of the pure copolymers. Standard deviations ±2%.
Ijms 22 09606 g003
Figure 4. Variations in the quantity Rg/Rh of polyplex particles of C12-PN-PG25 (a) and C12-PN-PG60 (b) and DNA with the [N]/[P] ratio. The lines through the data point are drawn to guide the eye. Data points are at [N]/[P] = 0 refer to the aggregates of the pure copolymers. Standard deviations ±2%.
Figure 4. Variations in the quantity Rg/Rh of polyplex particles of C12-PN-PG25 (a) and C12-PN-PG60 (b) and DNA with the [N]/[P] ratio. The lines through the data point are drawn to guide the eye. Data points are at [N]/[P] = 0 refer to the aggregates of the pure copolymers. Standard deviations ±2%.
Ijms 22 09606 g004
Figure 5. TEM images of C12-PN-PG25 polyplex with DNA at [N]/[P] = 10:1.
Figure 5. TEM images of C12-PN-PG25 polyplex with DNA at [N]/[P] = 10:1.
Ijms 22 09606 g005
Figure 6. Bar graphs presenting viable cells as a percent of non-treated controls, tested by Trypan blue dye exclusion test by using automated cell counter Corning® against: (a) concentration of block copolymers C12-PN-PG25 and C12-PN-PG60 (X axis), the red rectangle indicate the concentration of the copolymers in the highest DNA content (µg·mL−1) used in corresponding polyplexes; (b) concentration of DNA in C12-PN-PG25 polyplexes at [N]/[P] ratios of 10:1 and 7.5:1; (c) concentration of DNA in C12-PN-PG60 polyplexes at [N]/[P] ratios of 10:1 and 7.5:1. Each bar represents the arithmetic mean ± SD of the percent viable cells of 3 separate experiments.
Figure 6. Bar graphs presenting viable cells as a percent of non-treated controls, tested by Trypan blue dye exclusion test by using automated cell counter Corning® against: (a) concentration of block copolymers C12-PN-PG25 and C12-PN-PG60 (X axis), the red rectangle indicate the concentration of the copolymers in the highest DNA content (µg·mL−1) used in corresponding polyplexes; (b) concentration of DNA in C12-PN-PG25 polyplexes at [N]/[P] ratios of 10:1 and 7.5:1; (c) concentration of DNA in C12-PN-PG60 polyplexes at [N]/[P] ratios of 10:1 and 7.5:1. Each bar represents the arithmetic mean ± SD of the percent viable cells of 3 separate experiments.
Ijms 22 09606 g006
Figure 7. Fluorescent microscopy of HeLa cells, incubated for 24 or 48 h with C12-PN-PG25 and DNA (a) and C12-PN-PG60 and DNA (b) polyplexes at [N]/[P] ratios of 10:1 and 7.5:1. All images within an experiment were taken under identical settings. The thick arrows show clustered internalized polyplex nanoparticles. The arrowheads show structures most probably located around the cells stacked to the cellular membrane. The thin arrows show secondary staining of the cellular DNA due to some release of the dye.
Figure 7. Fluorescent microscopy of HeLa cells, incubated for 24 or 48 h with C12-PN-PG25 and DNA (a) and C12-PN-PG60 and DNA (b) polyplexes at [N]/[P] ratios of 10:1 and 7.5:1. All images within an experiment were taken under identical settings. The thick arrows show clustered internalized polyplex nanoparticles. The arrowheads show structures most probably located around the cells stacked to the cellular membrane. The thin arrows show secondary staining of the cellular DNA due to some release of the dye.
Ijms 22 09606 g007
Table 1. Characteristics of block copolymer precursors, amine-functional copolymers, and the corresponding aggregates in aqueous media.
Table 1. Characteristics of block copolymer precursors, amine-functional copolymers, and the corresponding aggregates in aqueous media.
PrecursorsAggregates of Modified Block Copolymers
CodeDPaPAGEDPaPGMna (g·mol−1)ÐMbCodedhc (nm)PdIcζ c (mV)
C12-PAGE-PG25441664001.08C12-PN-PG25184.20.29341.1
C12-PAGE-PG60446610,1001.06C12-PN-PG60173.90.23240.7
a Number-average degrees of polymerization (DP) and molar masses (Mn), as determined by 1H NMR analyses. b Molar-mass dispersity (ÐM), as determined before the deprotection of the PG-hydroxyl groups by GPC in THF vs. polystyrene standards. c Average diameters (dh), polydispersity indexes (PdI, distribution of particle size), and zeta potentials (ζ) of the modified block copolymer aggregates in aqueous media, as determined by DLS and electrophoretic light scattering. c Standard deviations for dh and ζ are ±2% and ±3%, respectively.
Table 2. Characteristics from DLS and electrophoretic LS measurements of polyplexes from C12-PN-PG25 and C12-PN-PG60 at various [N]/[P] ratios in aqueous media.
Table 2. Characteristics from DLS and electrophoretic LS measurements of polyplexes from C12-PN-PG25 and C12-PN-PG60 at various [N]/[P] ratios in aqueous media.
[N]/[P]dha (nm)PdIζa (mV)
Polyplexes from C12-PN-PG25 and DNA
1:1
2.5:1
5:1
7.5:1
10:1
127.60.108−25.7
112.80.15337.4
95.40.07335.3
92.00.11334.2
78.70.13535.7
Polyplexes from C12-PN-PG60 and DNA
1:1
2.5:1
5:1
7.5:1
10:1
181.10.090−27.9
131.20.09036.8
119.50.18740.7
100.80.14838.9
126.60.19141.8
a Standard deviations for dh and ζ are ±2% and ±3%, respectively.
Table 3. Calculated half-maximal inhibitory concentration (IC50) in µg·mL−1 of C12-PN-PG25 and C12-PN-PG60 copolymers and corresponding polyplexes at various [N]/[P] ratios.
Table 3. Calculated half-maximal inhibitory concentration (IC50) in µg·mL−1 of C12-PN-PG25 and C12-PN-PG60 copolymers and corresponding polyplexes at various [N]/[P] ratios.
[N]/[P]A549MCF-7HeLa
Copolymer aggregates and polyplexes from C12-PN-PG25 and DNA
Initial C12-PN-PG25 aggregates
1:1
2.5:1
5:1
7.5:1
10:1
32.2 ± 5.129.8 ± 3.527.7 ± 2.8
20.7 ± 1.826.2 ± 3.131.5 ± 3.6
24.7 ± 2.228.8 ± 2.624.6 ± 5.1
37.2 ± 3.447.2 ± 3.353.7 ± 4.7
46.5 ± 2.839.8 ± 4.152.8 ± 3.4
49.8 ± 3.148.2 ± 2.543.7 ± 2.9
Copolymer aggregates and polyplexes from C12-PN-PG60 and DNA
Initial C12-PN-PG60 aggregates
1:1
2.5:1
5:1
7.5:1
10:1
22.0 ± 4.4 *24.6 ± 4.2 *28.7 ± 3.2
35.5 ± 2.719.8 ± 4.6 *32.6 ± 3.5
40.3 ± 1.925.6 ± 2.839.5 ± 4.8
44.2 ± 2.649.5 ± 3.556.6 ± 3.7
50.1 ± 3.346.7 ± 3.748.7 ± 4.2
48.8 ± 4.142.2 ± 3.943.8 ± 2.9
Each data point represents the arithmetic mean ± SD of 3 independent experiments performed in octuplicates. Statistical significance was calculated by ordinary one-way ANOVA, followed by Tukey’s multiple comparisons test, and * p-values ≤ 0.05 were considered to indicate statistical significance as these analyses of variances did not find significant differences between the groups.
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Share and Cite

MDPI and ACS Style

Kalinova, R.; Valchanova, M.; Dimitrov, I.; Turmanova, S.; Ugrinova, I.; Petrova, M.; Vlahova, Z.; Rangelov, S. Functional Polyglycidol-Based Block Copolymers for DNA Complexation. Int. J. Mol. Sci. 2021, 22, 9606. https://doi.org/10.3390/ijms22179606

AMA Style

Kalinova R, Valchanova M, Dimitrov I, Turmanova S, Ugrinova I, Petrova M, Vlahova Z, Rangelov S. Functional Polyglycidol-Based Block Copolymers for DNA Complexation. International Journal of Molecular Sciences. 2021; 22(17):9606. https://doi.org/10.3390/ijms22179606

Chicago/Turabian Style

Kalinova, Radostina, Miroslava Valchanova, Ivaylo Dimitrov, Sevdalina Turmanova, Iva Ugrinova, Maria Petrova, Zlatina Vlahova, and Stanislav Rangelov. 2021. "Functional Polyglycidol-Based Block Copolymers for DNA Complexation" International Journal of Molecular Sciences 22, no. 17: 9606. https://doi.org/10.3390/ijms22179606

APA Style

Kalinova, R., Valchanova, M., Dimitrov, I., Turmanova, S., Ugrinova, I., Petrova, M., Vlahova, Z., & Rangelov, S. (2021). Functional Polyglycidol-Based Block Copolymers for DNA Complexation. International Journal of Molecular Sciences, 22(17), 9606. https://doi.org/10.3390/ijms22179606

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop